Adverum Biotechnologies Inc (NASDAQ: ADVM) stock closed at $3.52 on 9/5/25 after a major increase of 11.0%. Moreover, unusually high trading volume at 155% of normal accompanied the advance. The stock has risen 15.8% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Adverum Biotechnologies has a slightly negative Appreciation Score of 38 and a very low Power Rating of 4, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment